Impact of the COVID-19 pandemic on hospitalizations with hepatocellular carcinoma in the United States.

Peter Konyn Brandon J Perumpail Karn Wijarnpreecha George Cholankeril Andrew A Li Donghee Kim

Published in: Expert review of gastroenterology & hepatology (2024)

Hospitalization rates for viral hepatitis-related HCC remained stable, while those for HCC due to ALD and NAFLD increased during the COVID-19 pandemic.

Keyphrases

sars cov
drug induced